167 related articles for article (PubMed ID: 16688341)
1. Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.
Garanger E; Boturyn D; Coll JL; Favrot MC; Dumy P
Org Biomol Chem; 2006 May; 4(10):1958-65. PubMed ID: 16688341
[TBL] [Abstract][Full Text] [Related]
2. Multimeric Presentation of RGD Peptidomimetics Enhances Integrin Binding and Tumor Cell Uptake.
Pina A; Kadri M; Arosio D; Dal Corso A; Coll JL; Gennari C; Boturyn D
Chemistry; 2020 Jun; 26(33):7492-7496. PubMed ID: 32227540
[TBL] [Abstract][Full Text] [Related]
3. New potent and selective αvβ
Wu Z; Cheng X; Hong H; Zhao X; Zhou Z
Bioorg Med Chem Lett; 2017 May; 27(9):1911-1913. PubMed ID: 28351594
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD and
Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
[TBL] [Abstract][Full Text] [Related]
5. Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.
Sancey L; Lucie S; Garanger E; Elisabeth G; Foillard S; Stéphanie F; Schoehn G; Guy S; Hurbin A; Amandine H; Albiges-Rizo C; Corinne AR; Boturyn D; Didier B; Souchier C; Catherine S; Grichine A; Alexeï G; Dumy P; Pascal D; Coll JL; Jean-Luc C
Mol Ther; 2009 May; 17(5):837-43. PubMed ID: 19259068
[TBL] [Abstract][Full Text] [Related]
6. Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion.
Villard V; Kalyuzhniy O; Riccio O; Potekhin S; Melnik TN; Kajava AV; Rüegg C; Corradin G
J Pept Sci; 2006 Mar; 12(3):206-12. PubMed ID: 16103993
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel dual-cyclic RGD peptides for α
Liu J; Cheng X; Tian X; Guan D; Ao J; Wu Z; Huang W; Le Z
Bioorg Med Chem Lett; 2019 Apr; 29(7):896-900. PubMed ID: 30732943
[TBL] [Abstract][Full Text] [Related]
9. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
[TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
[TBL] [Abstract][Full Text] [Related]
11. Multiple N-methylation by a designed approach enhances receptor selectivity.
Chatterjee J; Ovadia O; Zahn G; Marinelli L; Hoffman A; Gilon C; Kessler H
J Med Chem; 2007 Nov; 50(24):5878-81. PubMed ID: 17973471
[TBL] [Abstract][Full Text] [Related]
12. Photocontrol of cell adhesion processes: model studies with cyclic azobenzene-RGD peptides.
Schütt M; Krupka SS; Milbradt AG; Deindl S; Sinner EK; Oesterhelt D; Renner C; Moroder L
Chem Biol; 2003 Jun; 10(6):487-90. PubMed ID: 12837381
[TBL] [Abstract][Full Text] [Related]
13. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
[TBL] [Abstract][Full Text] [Related]
14. Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands.
Mingozzi M; Dal Corso A; Marchini M; Guzzetti I; Civera M; Piarulli U; Arosio D; Belvisi L; Potenza D; Pignataro L; Gennari C
Chemistry; 2013 Mar; 19(11):3563-7. PubMed ID: 23424096
[No Abstract] [Full Text] [Related]
15. Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates.
Borbély A; Thoreau F; Figueras E; Kadri M; Coll JL; Boturyn D; Sewald N
Chemistry; 2020 Feb; 26(12):2602-2605. PubMed ID: 31943410
[TBL] [Abstract][Full Text] [Related]
16. Structure-Activity Relationship of RGD-Containing Cyclic Octapeptide and αvβ3 Integrin Allows for Rapid Identification of a New Peptide Antagonist.
Silva A; Xiao W; Wang Y; Wang W; Chang HW; Ames JB; Lam KS; Zhang Y
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349271
[TBL] [Abstract][Full Text] [Related]
17. Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.
Casiraghi G; Rassu G; Auzzas L; Burreddu P; Gaetani E; Battistini L; Zanardi F; Curti C; Nicastro G; Belvisi L; Motto I; Castorina M; Giannini G; Pisano C
J Med Chem; 2005 Dec; 48(24):7675-87. PubMed ID: 16302808
[TBL] [Abstract][Full Text] [Related]
18. Bifunctional ligands that target cells displaying the alpha v beta3 integrin.
Owen RM; Carlson CB; Xu J; Mowery P; Fasella E; Kiessling LL
Chembiochem; 2007 Jan; 8(1):68-82. PubMed ID: 17154219
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.
Salvati M; Cordero FM; Pisaneschi F; Melani F; Gratteri P; Cini N; Bottoncetti A; Brandi A
Bioorg Med Chem; 2008 Apr; 16(8):4262-71. PubMed ID: 18343671
[TBL] [Abstract][Full Text] [Related]
20. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
